Research Frontiers Incorporated
REFR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.39 | 0.56 | -0.54 | 1.36 |
| FCF Yield | -1.38% | -6.80% | -3.57% | -3.32% |
| EV / EBITDA | -48.05 | -16.97 | -23.46 | -30.10 |
| Quality | ||||
| ROIC | -36.97% | -53.71% | -50.72% | -40.03% |
| Gross Margin | 80.27% | -159.42% | 67.55% | -99.67% |
| Cash Conversion Ratio | 0.60 | 1.20 | 0.82 | 0.98 |
| Growth | ||||
| Revenue 3-Year CAGR | 35.26% | -10.36% | -13.31% | -6.88% |
| Free Cash Flow Growth | 65.58% | -5.16% | -20.97% | 21.82% |
| Safety | ||||
| Net Debt / EBITDA | 0.59 | 1.19 | 1.54 | -0.21 |
| Interest Coverage | 0.00 | 0.00 | -59.37 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 61.03 | 394.77 | 250.64 | 230.71 |